Electronic Servitor Publication Network (OTCQB: XESP), a market disruptor for B2B companies using cutting-edge data analysis and smart technology, has announced a new Channel Partner with the addition of InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://ibn.fm/fw5k4). The XESP Channel Partner Program allows digital and traditional agencies who […]

Fuel cells use an oxidation-reduction reaction to convert fuel into electricity, making them critical to electrification initiatives aimed at improving air quality and reducing fossil fuel dependence. The technology is constantly evolving, however its ultimate success hinges on the availability of high-purity graphite for specific components within the fuel cell stack. Reflex Advanced Materials Corp. […]

Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is constantly exploring new ways to grow and improve the financial sector, specifically in line with creating and growing a global financial services ecosystem that addresses unmet mobile needs. Its focus has been on industrialized and developed countries and markets, all built on the […]

Commercial freight transportation technology developer Freight Technologies (NASDAQ: FRGT), aka Fr8Tech, is quickly moving toward the next stage in its evolution by incorporating artificial intelligence controls into its infrastructure, beginning with the appointment of Dr. Umberto León-Domínguez to oversee the creation of a dedicated AI development department within Fr8Tech. León-Domínguez’s appointment as the director of […]

Golf is about doing something you like, with people you like – what a concept. It’s hard to blame players and golf lovers from feeling blindsided by the announcement of a full-blown merger between two of golf’s major tours. The unexpected agreement between PGA Tour commissioner Jay Monahan and Saudi businessman Yasir bin Othman Al-Rumayyan, […]

Mark Berger, M.D., Chief Medical Officer of Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing gene therapies for patients with cancer and diabetes was featured in a recent Bell2Bell Podcast episode (https://ibn.fm/ZnVPJ). Dr. Berger talked about the Safety Review Committee (“SRC”) approval to advance to the Phase 2 expansion portion of […]

The NVIDIA Omniverse platform enables real-time simulation and 3D visualization for metaverse applications by providing a shared virtual environment where users can collaborate to engineer real-world scenarios. Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently gave the Omniverse an upgrade by integrating its Vista-X120 Plus lidar into DRIVE Sim, […]

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, including the company’s patented DehydraTECH(TM) technology, recently reported additional findings from its diabetes animal study DIAB-A22-1, as well as updates on two other applied R&D programs for dementia (DEM-A22-1) and epilepsy (EPIL-A21-1). In March, Lexaria announced that it had completed initial testing using DehydraTECH-CBD […]

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products mainly for treating infectious and autoimmune diseases, just announced that it has signed an exclusive worldwide license agreement to develop and commercialize VHH antibodies (“NanoAbs”) that target Interleukin-17 (“IL-17”). The license agreement is part of a broad-based collaboration with […]

Electronic Servitor Publication Network (OTCQB: XESP), a growth-focused digital activation and engagement solutions innovator and provider targeting B2B companies, recently announced the signing of a client agreement with Investor Brand Network (“IBN”), a multifaceted financial news and publishing company consisting of more than 60 trusted investor-facing brands (https://ibn.fm/a0nBS). The agreement seeks to enhance IBN’s growth […]